Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
2021 · npj Precision Oncology · 270 citations
https://doi.org/10.1038/s41698-021-00168-1
G
G. Emerens Wensink
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
33
Papers
712
Citations
10
h-index
11
i10-index
G. Emerens Wensink is an academic researcher from Utrecht University. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Cancer Cells and Metastasis & Cancer Genomics and Diagnostics. The author has an h-index of 10, co-authored 29 publications.
ORCID: 0000-0002-4103-5811Papers by this author
worksCo-cultures of colon cancer cells and cancer-associated fibroblasts recapitulate the aggressive features of mesenchymal-like colon cancer
2023 · Frontiers in Immunology · 89 citations
https://doi.org/10.3389/fimmu.2023.1053920
Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response
2024 · Journal of Experimental & Clinical Cancer Research · 43 citations
https://doi.org/10.1186/s13046-024-02980-6
Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era
2020 · British Journal of Cancer · 25 citations
https://doi.org/10.1038/s41416-020-01076-0
Survival of Patients with Deficient Mismatch Repair Versus Proficient Mismatch Repair Metastatic Colorectal Cancer Receiving Curative-Intent Local Treatment of Metastases in a Nationwide Cohort
2023 · Annals of Surgical Oncology · 3 citations
https://doi.org/10.1245/s10434-023-13974-7
Impact of treatment history on drug resistance of metastatic colorectal cancer organoids
2025 · iScience · 0 citations
https://doi.org/10.1016/j.isci.2025.113801
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat